KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Equity Ratio (2016 - 2025)

Exact Sciences has reported Equity Ratio over the past 16 years, most recently at 0.41 for Q4 2025.

  • Quarterly Equity Ratio rose 1.1% to 0.41 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.41 through Dec 2025, up 1.1% year-over-year, with the annual reading at 0.41 for FY2025, 1.1% up from the prior year.
  • Equity Ratio was 0.41 for Q4 2025 at Exact Sciences, down from 0.42 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.54 in Q1 2021 and troughed at 0.41 in Q4 2024.
  • The 5-year median for Equity Ratio is 0.49 (2023), against an average of 0.48.
  • Year-over-year, Equity Ratio surged 30.73% in 2021 and then dropped 16.63% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.51 in 2021, then decreased by 3.56% to 0.49 in 2022, then dropped by 0.55% to 0.49 in 2023, then fell by 16.63% to 0.41 in 2024, then grew by 1.1% to 0.41 in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Equity Ratio are 0.41 (Q4 2025), 0.42 (Q3 2025), and 0.43 (Q2 2025).